指南与共识泌尿生殖心血管介入CTDSA

欧洲泌尿生殖放射学会对比剂使用建议:法国肾脏病医师实践调查、文献回顾及法国肾脏病、重症肾脏病与青年肾脏病组织评论

[ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT].
指南 / 共识 · Nephrol Ther · 2021-02-05

本文通过电子问卷收集266份法国肾脏病医师回复,评估其对欧洲泌尿生殖放射学会对比剂使用建议的知晓与执行情况,并结合文献更新进行评论。结果显示该建议在受访医师中知晓率低,实际预防措施比建议更频繁且更早启动,肾素-血管紧张素-醛固酮系统抑制剂停药情况与建议相反。

要点

  • 欧洲泌尿生殖放射学会建议在法国肾脏病医师中知晓率低,临床实践与建议存在差异。
  • 与建议一致,水化被作为一线预防措施,主要使用生理盐水和碳酸氢盐。
  • 与建议相反,肾素-血管紧张素-醛固酮系统抑制剂在对比剂注射前常被停用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Contrast media administration is classically considered to cause or worsen kidney failure. Recent data may moderate this assertion. The European Society of Urogenital Radiology recently published guidelines re-evaluating the precautions before administering contrast media. The present work evaluates the practice of French nephrologists, and provides a commentary on these recommendations based on an updated review of the literature. We conducted survey among French nephrologists, using an electronic questionnaire distributed by the Société Francophone de Néphrologie, Dialyse et Transplantation, the French Intensive care Renal Network and the Club des Jeunes Néphrologues. 266 responses were collected. The European Society of Urogenital Radiology guidelines are poorly known among the panel of nephrologists. Their practices differ from the guidelines by the more frequent and earlier implementation of measures to prevent renal failure post contrast media. In accordance with the guidelines, hydration is prescribed as a first-line preventive measure, mainly with saline and bicarbonate. Inhibitors of the renin-angiotensin-aldosterone system are frequently discontinued before an injection of contrast media, contrary to what is recommended. In conclusion, the European Society of Urogenital Radiology guidelines, which the working group endorses, but which are still too little known and applied in clinical nephrology in France, prompt nephrologists to lift some of the restrictions on the use of PCI as well as on the continuation of ARS inhibitors before injecting PCI.

来源:Nephrol Ther,查看原文。版权归原作者所有。

引用

  1. de Laforcade L, Bobot M, Bellin MF, et al. [ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT]. Nephrol Ther. 2021. PMID: 33551369. doi:10.1016/j.nephro.2020.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。